ArticleScientific reports2026
Association of serum uric acid to high density lipoprotein cholesterol ratio with stroke.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Stroke, as the second leading cause of death globally, is characterized by high disability and mortality rates and urgently needs biomarkers for risk stratification. This study aims to use data from the China Health and Retirement Longitudinal Study (CHARLS) cohort to explore the association of the uric acid to HDL-C ratio (UHR), BMI with incident stroke. A total of 3756 participants aged 45 and above without a history of stroke were included from the CHARLS data from 2011 to 2020. Stroke events were confirmed through follow up data. UHR was calculated as the ratio of serum uric acid (mg/dL) to high density lipoprotein cholesterol (mg/dL). Statistical methods such as the Cox proportional hazards regression model, restricted cubic spline analysis, mediation effect test (Bootstrap method), and and multiplicative and additive interactions analysis were used to systematically evaluate the association of the combined UHR and BMI indicators with stroke risk. The UHR was significantly associated with stroke risk (HR = 1.03, p = 0.005), with the highest UHR group having 1.61 times the risk of the lowest group (p = 0.003). Subgroup analysis indicated that this association was significant in the non-diabetic population (p < 0.001) but not in the diabetic population (interaction p = 0.002). UHR mediated 18% of the association between BMI and stroke risk (95% CI 6.7-38%). No significant multiplicative and additive interactions were found between BMI and UHR on incident stroke.Restricted cubic spline analysis showed an approximately linear dose-response relationship between UHR and stroke risk (p for non linearity = 0.917). The study results indicate that UHR is significantly and positively correlated with stroke risk, and its value in stroke risk stratification is significantly enhanced when used in combination with BMI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.